Matão Preventing Stroke (MaPS): a Stroke Register Study (MaPS)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03391102 |
|
Recruitment Status :
Recruiting
First Posted : January 5, 2018
Last Update Posted : January 5, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Stroke is one of the most important cause of mortality and disability in Brazil. The city of Matão, located in São Paulo state, with a population around 80.000 inhabitants, has conditions to develop a community-based stroke study, which can answer important questions regarding epidemiological data over the time.
Therefore, the purpose of this prospective community based study is to observe trends in stroke incidence, types and sub-types of stroke, risk factors, prognosis, 30 days and one year case-fatality during a follow-up of ten years.
This study offers the opportunity to conduct an epidemiological study of high quality which can obtain data to formulate public politics to reduce the social and economic impact of stroke in Brazil.
| Condition or disease | Intervention/treatment |
|---|---|
| Stroke | Other: Observational study |
Show detailed description
| Study Type : | Observational [Patient Registry] |
| Estimated Enrollment : | 840 participants |
| Observational Model: | Ecologic or Community |
| Time Perspective: | Prospective |
| Target Follow-Up Duration: | 10 Years |
| Official Title: | Matão Preventing Stroke (MaPS): Stroke Register in City of Matão, Brazil |
| Actual Study Start Date : | August 2015 |
| Estimated Primary Completion Date : | July 2018 |
| Estimated Study Completion Date : | July 31, 2025 |
- Annual incidence of first-ever-stroke per 100 000 inhabitants [ Time Frame: 1 year ]Number of first-ever stroke divided by the population at risk.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | Child, Adult, Older Adult |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
The study population belongs to Matão, Brazil, São Paulo state, located 300 km northwest of the state capital. The number od inhabitants in 2014 was estimated in 78.910 and in 2025, 80.791 habitants, with no difference in sex distribution.
The economy is mainly based on agricultural and industrial activities and on general services. Ethnicity is diverse, but most people are of white ethnicity, descendants of European immigrants. The population is urban and stable, with a low rate of interurban migration. Approximately 95% of all dwellings have piped water, a sewage network, and electricity.
Inclusion Criteria: All suspected stroke patients living in Matão at an address belonging to the city were included, regardless of age. The stroke criteria were those defined by the Word Health Organization: "rapidly developing clinical symptoms and/or signs of focal and at time global loss of cerebral function, with symptoms lasting more than 24 hours or leading to death, with no apparent cause other than that of vascular origin" 12 Although every stroke was recorded, only the first-ever-in-a-lifetime stroke was included in the analysis.
Exclusion Criteria: Patients not living in Matão, who did not fulfill the clinical criteria for stroke, with CT or RMI scan findings incompatible with a clinical suspicion of stroke, and with clinical evidence of a previous stroke event.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03391102
| Contact: Cewsar Minelli, PhD, MD | +55-16-33823388 | cdminelli@yahoo.com.br | |
| Contact: Lucileni A Borin, Ps | +55-16-33832527 | lucileni.borin@hopitalmatao.com.br |
| Brazil | |
| Hospital Carlos Fernando Malzoni | Recruiting |
| Matão, São Paulo, Brazil, 15990180 | |
| Contact: Cesar Minelli, PhD, MD +55- 1633823388 cdminelli@yahoo.com.br | |
| Principal Investigator: | Cesar Minelli, PhD, | Hospital Carlos Fernando Malzoni |
Publications of Results:
| Responsible Party: | Centro Neurológico de Pesquisa e Reabiitação, Brazil |
| ClinicalTrials.gov Identifier: | NCT03391102 |
| Other Study ID Numbers: |
Cenp-Reab |
| First Posted: | January 5, 2018 Key Record Dates |
| Last Update Posted: | January 5, 2018 |
| Last Verified: | December 2017 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Yes |
| Plan Description: | Data regarding demography and prognosis can be shared with other researchers. |
| Supporting Materials: |
Study Protocol Statistical Analysis Plan (SAP) Informed Consent Form (ICF) Clinical Study Report (CSR) Analytic Code |
| Time Frame: | Data will become avaliable on July, 2018 |
| Access Criteria: | Researches interested in stroke epidemiology |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Epidemiology Community-based study |
|
Stroke Cerebrovascular Disorders Brain Diseases Central Nervous System Diseases |
Nervous System Diseases Vascular Diseases Cardiovascular Diseases |

